AMDR President Selected to Speak at 2018 CleanMed Europe
AMDR is proud to announce that Dan Vukelich has been selected to speak on medical device reprocessing at the 2018 CleanMed Europe meeting in Nijmegen, Netherlands. His presentation, Lowering Your Hospital’s Environmental Footprint with Remanufacturing of
Beware: Anti-Reprocessing Tactics
Today, AMDR released an alert to hospitals and healthcare facilities advising of certain sales tactics which may undermine reprocessing programs. In spite of the economic pressure facing hospitals and the healthcare sector, several original equipment manufacturers (OEMs) obstruct
Reprocessed Medical Devices Market is Rising to a Valuation of US$3.35 bn in 2024, Says TMR
PRNewswire reports on how reprocessed medical devices market is rising to new heights. “As per the TMR report, the global reprocessed medical devices market is likely to rise at a robust 14.9% CAGR between 2016 and 2024,
Controlling Hospitals Assets
THE ISSUE: AMDR receives reports that sales reps for some OEMs are physically interfering with hospital assets in attempts to stop reprocessing and associated cost savings for hospitals. Of course, many hospitals make savings by
Contracting Restrictions
THE ISSUE: Most medical device companies and sales reps earn an income by selling new devices to hospitals. AMDR member reprocessors are aligned with healthcare partners by seeking to extend the value of existing medical
Forced Obsolescence Designed Into Devices
THE ISSUE: Billed as “innovation,” some medical device manufacturers introduce new models of existing technology that are designed to make it impossible to reprocesses and reuse them. When such generational innovation disallows reprocessing, the hospital